Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
Journal of Hematology & Oncology
|
February 13, 2025
First-in-human evaluation of memory-like NK cells with an IL-15 super-agonist and CTLA-4 blockade in advanced head and neck cancer
Roman M Shapiro, Michal Sheffer, Matthew A Booker, et al.
Science Immunology
|
January 24, 2025
Coordinated immune networks in leukemia bone marrow microenvironments distinguish response to cellular therapy
Katie Maurer, Cameron Y Park, Shouvik Mani, et al.
Blood
|
November 4, 2022
Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settings
Jacqueline S Garcia, Yael Flamand, Livius Penter, et al.
Nature
|
December 1, 2025
Sustained HIV-1 remission after heterozygous CCR5Δ32 stem cell transplantation
Christian Gaebler, Samad Kor, Kristina Allers, et al.
Nature Biotechnology
|
August 21, 2024
Systematic identification of minor histocompatibility antigens predicts outcomes of allogeneic hematopoietic cell transplantation
Nicoletta Cieri, Nidhi Hookeri, Kari Stromhaug, et al.
Blood
|
March 15, 2021
Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantation
Livius Penter, Yi Zhang, Alexandra Savell, et al.
Blood
|
January 27, 2023
Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease
Livius Penter, Yang Liu, Jacquelyn O Wolff, et al.
Blood Cancer Discovery
|
December 5, 2022
In Vivo Modeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic Vulnerabilities
Elisa Ten Hacken, Tomasz Sewastianik, Shanye Yin, et al.
The Journal of Clinical Investigation
|
June 25, 2024
Oncogene-induced TIM-3 ligand expression dictates susceptibility to anti-TIM-3 therapy in mice
Nana Talvard-Balland, Lukas M Braun, Karen O Dixon, et al.
Science Immunology
|
September 8, 2023
Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti-PD-1 in head and neck cancer
Giacomo Oliveira, Ann Marie Egloff, Alexander B Afeyan, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
Journal of Hematology & Oncology
|
February 13, 2025
First-in-human evaluation of memory-like NK cells with an IL-15 super-agonist and CTLA-4 blockade in advanced head and neck cancer
Roman M Shapiro, Michal Sheffer, Matthew A Booker, et al.
Science Immunology
|
January 24, 2025
Coordinated immune networks in leukemia bone marrow microenvironments distinguish response to cellular therapy
Katie Maurer, Cameron Y Park, Shouvik Mani, et al.
Blood
|
November 4, 2022
Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settings
Jacqueline S Garcia, Yael Flamand, Livius Penter, et al.
Nature
|
December 1, 2025
Sustained HIV-1 remission after heterozygous CCR5Δ32 stem cell transplantation
Christian Gaebler, Samad Kor, Kristina Allers, et al.
Nature Biotechnology
|
August 21, 2024
Systematic identification of minor histocompatibility antigens predicts outcomes of allogeneic hematopoietic cell transplantation
Nicoletta Cieri, Nidhi Hookeri, Kari Stromhaug, et al.
Blood
|
March 15, 2021
Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantation
Livius Penter, Yi Zhang, Alexandra Savell, et al.
Blood
|
January 27, 2023
Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease
Livius Penter, Yang Liu, Jacquelyn O Wolff, et al.
Blood Cancer Discovery
|
December 5, 2022
In Vivo Modeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic Vulnerabilities
Elisa Ten Hacken, Tomasz Sewastianik, Shanye Yin, et al.
The Journal of Clinical Investigation
|
June 25, 2024
Oncogene-induced TIM-3 ligand expression dictates susceptibility to anti-TIM-3 therapy in mice
Nana Talvard-Balland, Lukas M Braun, Karen O Dixon, et al.
Science Immunology
|
September 8, 2023
Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti-PD-1 in head and neck cancer
Giacomo Oliveira, Ann Marie Egloff, Alexander B Afeyan, et al.
Page
of 5